OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
Omna Sharma, Ali A. Sultan, Hong Ding, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 515

Showing 1-25 of 515 citing articles:

COVID-19 vaccine hesitancy worldwide: a systematic review of vaccine acceptance rates
Malik Sallam
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 388

COVID-19 vaccines: rapid development, implications, challenges and future prospects
Shivaji Kashte, Arvind Gulbake, Saadiq F. El‐Amin, et al.
Human Cell (2021) Vol. 34, Iss. 3, pp. 711-733
Open Access | Times Cited: 355

Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection
Seyed Hamid Safiabadi Tali, Jason J. LeBlanc, Zubi Sadiq, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 335

Covid‐19 vaccines and variants of concern: A review
Ikbel Hadj Hassine
Reviews in Medical Virology (2021) Vol. 32, Iss. 4
Open Access | Times Cited: 313

COVID‐19 vaccine acceptance in pregnant women
Şule Göncü Ayhan, Deniz Oluklu, Ayşegül Atalay, et al.
International Journal of Gynecology & Obstetrics (2021) Vol. 154, Iss. 2, pp. 291-296
Open Access | Times Cited: 288

The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review
Ibrahim Mohammed, Areej Nauman, Pradipta Paul, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 281

The COVID-19 pandemic face mask waste: A blooming threat to the marine environment
S. Selvakumar, Veeramuthu Ashokkumar, S Hariharan, et al.
Chemosphere (2021) Vol. 272, pp. 129601-129601
Open Access | Times Cited: 270

Side effects and perceptions following Sinopharm COVID-19 vaccination
Balsam Qubais Saeed, Rula Al‐Shahrabi, Shaikha Salah Alhaj, et al.
International Journal of Infectious Diseases (2021) Vol. 111, pp. 219-226
Open Access | Times Cited: 243

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 194

Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations
Nicholas G. Kounis, Ioanna Koniari, Cesare de Gregorio, et al.
Vaccines (2021) Vol. 9, Iss. 3, pp. 221-221
Open Access | Times Cited: 183

Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants
Veronika Tchesnokova, Hemantha D. Kulasekara, Lydia Larson, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 11
Open Access | Times Cited: 179

What Demographic, Social, and Contextual Factors Influence the Intention to Use COVID-19 Vaccines: A Scoping Review
Bara’ Abdallah AlShurman, Amber Fozia Khan, Christina Mac, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 17, pp. 9342-9342
Open Access | Times Cited: 151

The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis
Kazem Rahmani, Rasoul Shavaleh, Mahtab Forouhi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 151

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial
Francesco Di Pierro, Somia Iqtadar, Amjad Khan, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 2807-2816
Open Access | Times Cited: 150

Herpes zoster following inactivated COVID‐19 vaccine: A coexistence or coincidence?
Ecem Bostan, Başak Yalıcı‐Armağan
Journal of Cosmetic Dermatology (2021) Vol. 20, Iss. 6, pp. 1566-1567
Closed Access | Times Cited: 145

COVID‐19 vaccinations: The unknowns, challenges, and hopes
Kawthar Mohamed, Piotr Rzymski, Md Shahidul Islam, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1336-1349
Open Access | Times Cited: 119

COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations
Qian He, Qunying Mao, Jialu Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 111

Efficacy and safety of COVID-19 vaccines: a systematic review.
Kai Xing, Xiao-Yan Tu, Miao Liu, et al.
Zhongguo dangdai erke zazhi (2021) Vol. 23, Iss. 3, pp. 221-228
Closed Access | Times Cited: 108

A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges
Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed, et al.
VirusDisease (2022) Vol. 33, Iss. 1, pp. 1-22
Open Access | Times Cited: 98

Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant
Kanika Bansal, Sanjeet Kumar
Virus Research (2022) Vol. 315, pp. 198765-198765
Open Access | Times Cited: 71

Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 432-432
Open Access | Times Cited: 49

Page 1 - Next Page

Scroll to top